Inspire Investing LLC Grows Stock Holdings in West Pharmaceutical Services, Inc. (NYSE:WST)

Inspire Investing LLC boosted its holdings in West Pharmaceutical Services, Inc. (NYSE:WST) by 5.2% in the third quarter, Holdings Channel reports. The institutional investor owned 10,752 shares of the medical instruments supplier’s stock after acquiring an additional 535 shares during the quarter. Inspire Investing LLC’s holdings in West Pharmaceutical Services were worth $3,227,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also bought and sold shares of the business. Vanguard Group Inc. grew its stake in West Pharmaceutical Services by 1.2% in the 4th quarter. Vanguard Group Inc. now owns 9,002,632 shares of the medical instruments supplier’s stock valued at $3,170,007,000 after buying an additional 104,740 shares in the last quarter. Findlay Park Partners LLP grew its position in shares of West Pharmaceutical Services by 30.6% during the 1st quarter. Findlay Park Partners LLP now owns 597,106 shares of the medical instruments supplier’s stock valued at $236,281,000 after purchasing an additional 139,800 shares in the last quarter. Kayne Anderson Rudnick Investment Management LLC grew its position in shares of West Pharmaceutical Services by 6.8% during the 2nd quarter. Kayne Anderson Rudnick Investment Management LLC now owns 593,692 shares of the medical instruments supplier’s stock valued at $195,556,000 after purchasing an additional 37,702 shares in the last quarter. ProShare Advisors LLC grew its position in shares of West Pharmaceutical Services by 13.9% during the 1st quarter. ProShare Advisors LLC now owns 500,662 shares of the medical instruments supplier’s stock valued at $198,117,000 after purchasing an additional 61,247 shares in the last quarter. Finally, Sei Investments Co. grew its position in shares of West Pharmaceutical Services by 12.7% during the 2nd quarter. Sei Investments Co. now owns 401,026 shares of the medical instruments supplier’s stock valued at $132,095,000 after purchasing an additional 45,208 shares in the last quarter. 93.90% of the stock is currently owned by hedge funds and other institutional investors.

West Pharmaceutical Services Stock Up 1.7 %

WST opened at $294.91 on Friday. The company has a fifty day moving average price of $300.43 and a 200-day moving average price of $328.53. The firm has a market capitalization of $21.39 billion, a P/E ratio of 41.95, a price-to-earnings-growth ratio of 10.35 and a beta of 1.01. The company has a debt-to-equity ratio of 0.03, a current ratio of 2.34 and a quick ratio of 1.68. West Pharmaceutical Services, Inc. has a one year low of $265.00 and a one year high of $413.70.

West Pharmaceutical Services (NYSE:WST) last posted its quarterly earnings data on Thursday, July 25th. The medical instruments supplier reported $1.52 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.74 by ($0.22). West Pharmaceutical Services had a return on equity of 19.17% and a net margin of 18.25%. The company had revenue of $702.10 million for the quarter, compared to the consensus estimate of $729.36 million. During the same period in the prior year, the firm posted $2.11 earnings per share. The business’s revenue was down 6.9% on a year-over-year basis. Equities research analysts expect that West Pharmaceutical Services, Inc. will post 6.42 earnings per share for the current fiscal year.

Insider Transactions at West Pharmaceutical Services

In other news, VP Charles Witherspoon sold 1,029 shares of West Pharmaceutical Services stock in a transaction on Monday, August 19th. The shares were sold at an average price of $300.00, for a total transaction of $308,700.00. Following the completion of the sale, the vice president now directly owns 1,478 shares of the company’s stock, valued at approximately $443,400. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. 0.53% of the stock is currently owned by insiders.

West Pharmaceutical Services Profile

West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.